Introduction
Cells can modulate the expression of nuclear genes in response to changes in the activity level of their organelles. For example, mitochondria dysfunction induces the activation of transcription factors in a response called retrograde communication' (Parikh et al., 1987; Liao and Butow, 1993) . Several lines of evidence previously established that alterations in the mitochondrial activity result in changes in nuclear gene expression (Wang and Morais, 1997) . In yeast, numerous studies have shown that a retrograde signaling pathway can act as a homeostatic or stress response mechanism to adjust metabolic activities to the alterations of mitochondria activity. It has been particularly well characterized for the CIT2 gene, encoding a peroxisomal isoform of citrate synthase that catalyzes the ®rst step in the glyoxylate cycle. In cells lacking mitochondrial DNA (mtDNA), increased expression of CIT2 is dependent on the activation of RTG1 and RTG3 encoding basic helix±loop±helix leucine zipper (bHLH-Zip) transcription factors (Liao and Butow, 1993) . In yeast, detailed mechanisms on the regulation of the mitochondria to nucleus signaling and metabolic control through Rtg proteins in response to mitochondria impairment have been described recently (Komeili et al., 2000; Sekito et al., 2000) .
The interorganelle`retrograde communication' pathways have been described not only in yeast (Liao and Butow, 1993; Komeili et al., 2000; Sekito et al., 2000) but also in plant (May®eld, 1990 ) and mammalian cells (Biswas et al., 1999) . However, the signaling pathway(s) used by mitochondria to communicate the state of activity to the nucleus is still poorly understood in mammalian cells.
Mitochondrial activity plays a crucial role in cellular physiology, as emphasized recently by the discovery of a wide variety of human diseases caused by or associated with mitochondrial alterations such as genetic defects in mtDNA or nuclear DNA that affect the respiratory chain and ADP phosphorylation (Wallace, 1999) . Among these diseases, myoclonus epilepsy with ragged-red ®bers (MERRF) is a maternally inherited disorder characterized by point mutations in the mtDNA-encoded tRNA Lys gene which impairs respiration and mitochondrial protein synthesis (Lombes et al., 1989) . Cells cultured with ethidium bromide (EtBr) partly or completely lose their mtDNA (mtDNA-depleted or r0 cells) and consequently cannot carry out oxidative phosphorylation (OXPHOS) and thus glycolysis is their only source of ATP (King and Attardi, 1989) . Recently, these cells have been used to study mitochondrial disorders due to genetic defects such as deletions in mtDNA, depletion of mtDNA or reduction of mtDNA copy number (King and Attardi, 1989; Moraes et al., 1991) . These mtDNA-depleted cells usually have a proliferation defect characterized by a longer doubling time, as observed for mtDNA-depleted HeLa S3 and 143B cells (Vaillant and Nagley, 1995; Buchet and Godinot, 1998) , but no molecular control of the cell cycle after inhibition of mitochondria has been evidenced so far.
Mitochondrial dysfunction also greatly modi®es nuclear gene expression (Epstein et al., 2001) . Indeed, increased expression of ANT-1 and ATP synthase b-subunit mRNAs was described in skeletal muscle of patients with respiratory defects resulting from mtDNA point mutations (Heddi et al., 1993) , and increased mRNAs encoding cytochrome oxidase (COX IV and COX VIaL) were also observed in r0 cells (Li et al., 1995) . Biswas et al. (1999) recently described that in mouse C2C12 cells, the decrease of CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation
The EMBO Journal Vol. 21 Nos 1 & 2 pp. 53±63, 2002 ã European Molecular Biology Organization mtDNA content initiates a signaling pathway leading to the activation of JNK and increased transcription of ryanodine receptor-1 Ca 2+ release channel and COX Vb genes. While eukaryotic cells can respond to mitochondrial dysfunction by a modulation of nuclear gene expression, evidence for signaling pathways and transcriptional mechanisms are lacking in most instances. Interestingly, several genes encoding mitochondrial proteins contain CRE (cAMP response element) sequences such as some respiratory chain subunits (Scacco et al., 2000) , cytochrome c (Gopalakrishnan and Scarpulla, 1994) , manganese superoxide dismutase (Kim et al., 1999) or carnitine palmitoyltransferase (Brady et al., 1992) .
In this study, we analyzed the effect of mitochondrial activity inhibition on the signaling and transcriptional machinery of mammalian cells. We identi®ed CREbinding protein (CREB) as a new transcription factor involved in the`retrograde communication' pathways between impaired mitochondria and the nucleus. We used several cellular models: a mtDNA-depleted murine ®brosarcoma cell population (L929), a true r0 human osteosarcoma cell line (143B), a cybrid cell line with a nucleotide mutation (A8344G) in the mitochondriaencoded tRNA Lys gene and an acute inhibition of mitochondria in 293 cells treated with metabolic mitochondrial inhibitors. We found that mitochondrial activity impairment is suf®cient to trigger CREB phosphorylation on Ser133 by calcium/calmodulin kinase IV (CaMKIV). In turn, phosphorylated CREB mediates a proliferation defect in mtDNA-depleted L929 cells by increasing p53 transcriptional activity that leads to the up-regulation of p21 Waf1/Cip1 , a cyclin-dependent kinase inhibitor gene regulated by p53. Our results suggest that the activation of a`retrograde communication' signaling pathway initiated by a mitochondrial dysfunction could be an important modulator of the cell cycle in cells submitted to energetic stress conditions.
Results
Functional and morphological characterization of the mtDNA-depleted L929 cell line PCR analysis revealed that EtBr-treated L929 cells are dramatically depleted in but not completely devoid of mtDNA. As shown in Figure 1A , using speci®c primers for the D-loop fragment in mouse mtDNA, we ampli®ed a fragment of the expected size (823 bp) in L929 cells, but only a very weak band was obtained for EtBr-treated cells. No ampli®cation was obtained with nuclear DNA, con®rming the speci®city for mtDNA. Consistently, the mtDNA-encoded COX I protein was weakly stained in mtDNA-depleted L929 compared with parental cells ( Figure 1B) . The functional effect of EtBr treatment on oxidative phosphorylation was assessed further on in situ respiration as measured by the respiratory control ratio (RCR). EtBr treatment induces a complete inhibition of the oxidative respiration (RCR = 1) in mtDNA-depleted cells (see Supplementary data available at The EMBO Journal Online). The total cellular ATP measured in mtDNA-depleted L929 cells was reduced by 60% and was no longer sensitive to the uncoupler FCCP, suggesting that the residual ATP content in these cells is supplied by glycolysis (data not shown).
CREB is constitutively activated by phosphorylation on Ser133 in mtDNA-depleted L929 cells To address the question of whether or not the inhibition of mitochondrial activity modulates the transcriptional activity, L929 or mtDNA-depleted L929 cells were transiently co-transfected with a plasmid encoding b-galactosidase and different luciferase reporter constructs transactivated by various transcription factors. As illustrated in Figure 2A , the luciferase activity was increased speci®cally for the constructs driven either by the authentic a-inhibin promoter (Pei et al., 1991) or by the authentic c-fos promoter, both containing CRE sites. CREB transactivation is also observed in a r0 143B cell line or clonal cybrids obtained from r0 143B cells that have been repopulated with mtDNA from a MERRF patient harboring a tRNA Lys mutation (A8344G) (King and Attardi, 1989) . Luciferase activity was compared in L929, mtDNA-depleted L929 cells, cybrids containing either 100% mutated or wild-type mtDNA, and 143B and r0 143B cells after transient transfection with the luciferase reporter construct driven by the a-inhibin promoter ( Figure 2B ). The different cell lines associated with severe defects in respiratory chain activity show a signi®cant increase in CREB-dependent luciferase activity. This effect seems to be speci®c for mitochondrial inhibition, as glycolysis inhibition with 2-deoxy-D-glucose is without any effect on CREB activation (data not shown). In mtDNA-depleted L929 cells, the overexpression of K-CREB and M1-CREB, two dominant-negative mutants for CREB (Bonni et al., 1999) , completely inhibited the luciferase activity driven by the a-inhibin promoter ( Figure 2C ). Western blotting analysis revealed that CREB phosphorylation on Ser133 is induced in mtDNAdepleted L929 cells, mutated MERRF cybrids and r0 143B cells ( Figure 2D ). Confocal microscopy and subcellular fractionation±western blot analyses show that phosphorylated CREB is found mainly in nuclei of the different cell lines associated with a mitochondrial dysfunction (data not shown). To make sure that phosphorylated CREB is able to modify gene expression, we checked the amount of c-fos expression, a CREBregulated immediate-early gene (Hall et al., 2001) . As can be seen in Figure 2E , c-fos protein is more abundant in mtDNA-depleted cells.
Identi®cation of the kinase responsible for the phosphorylation of CREB We next examined the activity of several kinase cascades leading to CREB activation in mtDNA-depleted L929 cells. We ®rst measured the in vitro cAMP-dependent protein kinase (PKA) activity in cell homogenates, but no difference was observed between L929 and mtDNAdepleted cells, while PKA is activated in a time-dependent manner in cells treated with 100 mM dibutyryl-cAMP (see Supplementary data). We then tested whether CREB phosphorylation was mediated by a Ca 2+ -dependent mechanism. Cell treatment with BAPTA, an intracellular Ca 2+ chelator, inhibits luciferase activity observed in mtDNA-depleted L929 cells on both CREB reporter constructs ( Figure 3A) , while BCECF, an unrelated probe tested to rule out the potentially toxic effect, is without any effects (data not shown). We also con®rmed that intracellular calcium concentration in cells loaded with Fluo-3, a¯uorescent calcium indicator, is higher in mtDNA-depleted L929 cells ( Figure 3B ).
As calcium is able to activate several kinase pathways leading to CREB phosphorylation on Ser133 such as CaMKI, II or IV, p70S6K, rsk2, MSK, PKCs, Ras/Raf/ MAPK and MAPKAP-K2, allowing the interaction with the CREB-binding protein (CBP/p300) (De Cesare et al., 1999) , we used different inhibitors to modulate the CREBdependent luciferase activity. As shown in Figure 4A , only KN-93, a CaMK inhibitor, and W-7, a calmodulin antagonist, were able to inhibit CREB-dependent transcription signi®cantly, while inhibitors of the PKA (H-89), PKC (calphostin C), mitogen-activated protein kinase (PD 95089) or phosphatidylinositol 3-kinase (wortmannin) Fig. 3 . (A) Effect of a 6 h treatment with 20 mM BAPTA-AM on the CREB-sensitive luciferase activity after transfection of L929 (black) or mtDNA-depleted L929 (hatched) cells with luciferase reporter genes driven by either CREB-regulated c-fos or a-inhibin promoters. Luciferase activity was determined and expressed as RLU after normalization for b-galactosidase activity (n = 6; ***, signi®cantly different from mtDNA-depleted cells with P <0.001). (B) Intracellular calcium concentration ratio in L929 and mtDNA-depleted cells loaded with 10 mM Fluo-3-AM. Results are expressed in fold increase of control cells, and represent the mean 6 SD for n = 3 (***, signi®cantly different from L929 with P <0.001). pathway have no effect. We thus investigated the possible role of CaMKI, II, and IV in CREB activation. Expression of a dominant-negative form of CaMKIV (CaMKIV T200A) (Chatila et al., 1996) completely suppressed the activation of the CREB reporter construct in transfected mtDNA-depleted L929 cells, while overexpression of the wild-type enzyme enhanced the luciferase activity only in mtDNA-depleted cells ( Figure 4B ). When these cells are transiently transfected with plasmids encoding the wild type of different isoforms (CaMKI, II and IV), only CaMKIV overexpression is able to enhance the CREBdependent luciferase activity by an additional 2-fold increase ( Figure 4C ).
The crucial role of CaMKIV in the phosphorylation of CREB in mtDNA-depleted L929 cells was evidenced further by the fact that overexpression of dominantnegative CaMKIV T200A or KN-93 treatment dramatically inhibited CREB phosphorylation, as observed by western blot analysis ( Figure 5A ). The overexpression of the dominant-negative M1-CREB also inhibited phosphorylation of endogenous CREB, probably by competing for binding and subsequent phosphorylation ( Figure 5A ). Finally, endogenous CaMKII and CaMKIV were immunoprecipitated and their activity was determined in vitro. The results shown in Figure 5B and C clearly indicate that the CaMKIV activity is increased by 3-to 4-fold in mtDNAdepleted L929 cells while CaMKII activity seems to be unaffected. The slight increase observed in the CaMKII activity is most likely to be the result of the higher amount of the immunoprecipitated kinase used for the assay ( Figure 5C ). In conclusion, these results clearly support the hypothesis that CREB phosphorylation in mtDNAdepleted L929 cells is mediated by CaMKIV.
CREB phosphorylation is induced by inhibitors of mitochondrial activity
In order to determine whether CREB activation is induced directly by a mitochondrial activity impairment, we tested the effect of metabolic mitochondrial inhibitors on CREB activation. Phospho-CREB localization in cell lines treated with FCCP, oligomycin or antimycin A is almost exclusively nuclear, as shown for L929 cells in Figure 6A . Phosphorylated CREB is also transcriptionally active in cells treated with metabolic inhibitors, as demonstrated by (black) and mtDNAdepleted L929 (hatched) cells were transiently co-transfected with a plasmid encoding b-galactosidase, the CREB luciferase reporter construct driven by the a-inhibin promoter and an expression vector encoding wild-type CaMKIV or the dominant-negative form CaMKIV T200A. (C) Effect of overexpression of CaMKI, CaMKII and CaMKIV on the activation of the CREB luciferase reporter construct driven by the a-inhibin promoter. L929 (black) and mtDNA-depleted L929 (hatched) cells were transiently co-transfected as described in (B) with an expression vector encoding wild-type CaMKI, II or IV. Results are normalized for b-galactosidase activity, are expressed in fold increase of luciferase activity of the L929 control cells and represent the mean 6 SD for n = 3 (***, signi®cantly different from L929 with P <0.001; ###, signi®cantly different from mtDNA-depleted L929 cells with P <0.001). the activation of the CREB reporter gene construct ( Figure 6B ). Cell incubation with BAPTA and overexpression of dominant-negative form M1-CREB or CaMKIV T200A almost completely inhibited the luciferase activity triggered by the different mitochondrial inhibitors ( Figure 6B ). Using the Ca 2+ -sensitive photoprotein apoaequorin as a calcium probe, we con®rmed that free cytosolic [Ca 2+ ] cyt is increased in 293 cells treated with mitochondrial inhibitors while mitochondrial [Ca 2+ ] mt is decreased (see Supplementary data). Endogenous CaMKIV activity is also increased (5±7 times) in 293 cells after treatment with oligomycin, antimycin A or FCCP (see Supplementary data). Altogether, these results suggest that mitochondrial inhibitors are also able to trigger CREB phosphorylation through a CaMKIVdependent mechanism and they demonstrate that CREB activation induced by mitochondria dysfunction is not cell speci®c as it is observed in two different cell lines.
CaMKIV activity is differentially regulated by PP2A in cells affected by mitochondria dysfunction Once activated by phosphorylation on a single threonine residue by the calmodulin-dependent kinase kinase (CaMKK), CaMKIV activity becomes independent of both calcium and calmodulin (Park and Soderling, 1995) . However, CaMKIV is known to be inactivated by protein phosphatase 2A (PP2A) (Westphal et al., 1998) . To determine whether these enzymes exist as a complex in L929 and mtDNA-depleted L929 cells, we immunoprecipitated endogenous CaMKIV from cell lysates and analyzed the immune complexes by immunoblotting with an antibody speci®c for the PP2A catalytic C subunit. As shown in Figure 7A , PP2A catalytic C subunit coimmunoprecipitated with CaMKIV in L929 cells (lane 1), but the interaction is dramatically weaker in mtDNAdepleted L929 cells (lane 2). To make sure the differential interaction is caused by mitochondrial inhibition, we compared the co-immunoprecipitated PP2A in L929 cells treated with the different inhibitors. As shown in Figure 7A , antimycin A, FCCP and oligomycin are all able to impair the interaction between both enzymes. These results suggest that PP2A interaction with CaMKIV is weaker in mtDNA-depleted L929 cells and in cells submitted to the metabolic inhibitors. A very important question to answer is whether or not the weaker association of CaMKIV with PP2A observed in mtDNAdepleted cells is caused by CaMKIV's increased activity as a result of the higher calcium concentration or if the impaired association with PP2A is reponsible for causing the increase in CaMKIV. To address this question, we performed co-immunoprecipitation experiments between CaMKIV and PP2A in L929 cells treated with ionomycin, a calcium ionophore, or in mtDNA-depleted cells treated with KN-93 to inhibit CaMKIV activity. The results presented in Figure 7B clearly show that ionomycin treatment inhibits the interaction while the association is increased in mtDNA-depleted L929 cells treated with KN-93. These results support the ®rst hypothesis that the interaction can be modulated by the CaMKIV activity status.
Involvement of phosphorylated CREB in the cell proliferation defect A slower proliferation of mtDNA-depleted cells than parental cells has been observed in several cell lines and is usually attributed to the lower ATP content in these cells (King and Attardi, 1996; Morais, 1996) , but the molecular pathway is unknown. As stimulation of the cAMP pathway inhibits proliferation of some tumoral cell lines (Yokozaki et al., 1992) , we hypothesized that phosphorylated CREB contributes to the lower proliferation of the mtDNAdepleted L929 or L929 cells treated with an inhibitor of mitochondrial activity. As shown in Figure 8A , the [ 3 H]thymidine incorporation into mtDNA-depleted L929 cells and in oligomycin-treated L929 cells was strongly reduced as compared with L929. Therefore, we assessed the role of phosphorylated CREB on cell entry into S phase. L929 cells were transiently transfected with a control vector or with constructs encoding CREB dominant-negative mutants K-CREB and M1-CREB, 24 h before the addition of 8 mM oligomycin for 6 h. Oligomycin decreases [ 3 H]thymidine incorporation by almost 40±50% in both untransfected control cells and transfected control cells. However, this effect is largely reduced when cells overexpressed either K-CREB or M1-CREB ( Figure 8A) . Similarly, mtDNA-depleted L929 cells incorporated only 50% of [ 3 H]thymidine compared with parental cells, and the decrease can be signi®cantly reduced by K-CREB or M1-CREB overexpression ( Figure 8A) . A reduced decrease in the [ 3 H]thymidine incorporation was also observed when mtDNA-depleted L929 cells were transiently transfected with dominantnegative CaMKIV or treated with KN-93 ( Figure 8B ), two conditions that reduce the phosphorylation of CREB on Ser133 ( Figure 5A ). As a positive control, we showed that M1-CREB is also able to reduce the decrease of [ 3 H]thymidine incorporation in forskolin-treated L929 cells ( Figure 8B ). In conclusion, mtDNA depletion or mitochondrial inhibitors such as oligomycin appear to inhibit cell cycle entry into S phase through the activation of CREB transcription factor.
Phosphorylated CREB modi®es transactivation of p53 leading to p21 overexpression in mtDNA-depleted L929 cells Finally, we delineated the mechanism by which phosphorylated CREB could control the cell cycle of mtDNAdepleted L929 cells. Inspired by the recent ®ndings that phosphorylated CREB strongly and directly interacts with the N-terminus of the p53 tumor suppressor protein (Giebler et al., 2000) , we tested the interaction between p53 and CREB as well as the transcriptional activity of p53 in mtDNA-depleted L929 cells. As shown in Figure 9A , 
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CREB physically interacts with p53 in a phosphorylationdependent manner. p53 tumor suppressor protein was immunoprecipitated from L929 and mtDNA-depleted L929 cells and the amount of co-immunoprecipitated CREB was analyzed by western blotting. The total CREB co-immunoprecipitated in mtDNA-depleted L929 cells is more abundant than in L929 control cells ( Figure 9A , lanes 1 and 2). This protein±protein interaction is mediated by the phosphorylation status of CREB, as overexpression of M1-CREB, a non-phosphorylable CREB protein, completely abolished the interaction in mtDNA-depleted L929 cells (lane 5). In both cell lines, forskolin treatment to induce the phosphorylation of CREB results in an increase of CREB associated with p53 (lanes 7 and 8) while the overexpression of M1-CREB before forskolin stimulation decreases CREB protein binding to p53 (lanes 3 and 4) . The physical interaction between phosphorylated CREB and p53 tumor suppressor protein observed in mtDNA-depleted L929 cells led us to address the question of whether or not the binding of phosphorylated CREB to p53 facilitates the p53-dependent transcription. We thus performed transient transfection assays with a p53-dependent luciferase reporter gene. L929 or mtDNA-depleted L929 cells were transiently transfected with a reporter plasmid carrying 13 copies of a p53-responsive promoter driving expression of the luciferase gene (pG13-Luc). As observed in Figure 9B , the luciferase activity is strongly increased in mtDNA-depleted L929 cells (28-fold increase) while co-transfection of either M1-CREB or CaMKIV (T200A) signi®cantly inhibited p53-dependent luciferase activity. As expected, transfection of a p53 expression plasmid dramatically stimulated luciferase in L929 cells but, interestingly, the overexpression of p53 in mtDNA-depleted L929 cells resulted in an additional 2-fold stimulation ( Figure 9B ). As forskolin enhances CREB interaction with p53, we tested its effect on the expression of the p53 reporter gene in L929 cells. As observed in Figure 9C , forskolin also triggers p53-dependent luciferase expression (69-fold increase) and the stimulation can be partially inhibited by H-89, a PKA inhibitor. These effects are even stronger when L929 cells are transiently transfected with a plasmid encoding wild-type p53 before the stimulation with forskolin ( Figure 9C) .
To address the biological relevance of the phosphorylated CREB pathway on p53-dependent transcription function, we analyzed the expression of an endogenous p53-responsive gene. We selected p21 Waf1/Cip1 , a cyclindependent kinase inhibitor gene, and examined its expression in L929 and mtDNA-depleted L929 cells. Western blot analysis revealed that the p21 protein level is increased in mtDNA-depleted L929 cells while little or no change in p53 tumor suppressor protein level was observed ( Figure 10A) . Furthermore, the level of p21 expression can be modulated by conditions that affect CREB phosphorylation status. Indeed, as observed in Figure 10B , forskolin stimulation increases p21 expression in L929 cells while inhibition of CaMKIV activity by KN-93 or overexpression of dominant-negative M1-CREB dramatically decreases p21 abundance in mtDNA-depleted cells. These results support a link between CREB activation and p21 expression.
Discussion
In this study, we report a new signaling pathway initiated by a dysfunction of the mitochondria and we analyzed its effect on transcription activation and cell proliferation. We used several models to study the cellular response to inhibition of mitochondrial activity: mtDNA-depleted L929 and r0 143B cell lines chronically treated with EtBr and a homoplasmic cybrid cell line relevant for MERRF disease which is mutated in a single nucleotide (A8344G) in the mtDNA-encoded tRNA Lys (King and Attardi, 1989) . In all these cell lines, we found that CREB was phosphorylated on Ser133, localized in the nucleus and was able to trigger the transcription of a luciferase reporter gene driven by the authentic a-inhibin promoter containing several CRE consensus binding sites.
We con®rmed the direct role of a mitochondrial activity impairment in CREB activation by testing the effects of FCCP, oligomycin and antimycin A. All these metabolic mitochondrial inhibitors were able to trigger CREBdependent luciferase activity. In the different models used to study mitochondrial dysfunction, CREB-sensitive luciferase expression is completely inhibited by K-CREB and M1-CREB, two CREB dominant-negative mutants (Bonni et al., 1999) . Nuclear localization of phosphorylated CREB on Ser133 induced by metabolic inhibition was con®rmed by confocal microscopy, while CREB expression was unchanged by the treatments, as analyzed by western blotting (data not shown).
Besides PKA, several kinases such as CaMKs, p70S6K, rsk2, MSK and MAPKAP-K2 are able to phosphorylate CREB on its transcriptional regulatory site, allowing interaction with the CREB-binding protein (CBP/p300) (De Cesare et al., 1999) . Mitochondrial inhibition is not known to have any effect on the cAMP pathway and we did not observe any PKA activation in mtDNA-depleted L929 cells. Our results suggest an important role for a CaMK in CREB activation. Identi®cation of the speci®c-ally activated CaMKIV by mitochondrial dysfunction and the fact that it is responsible for CREB phosphorylation was based on the results obtained from direct in vitro kinase assays and from the correlated inhibition of both CREB phosphorylation and luciferase activity by the overexpression of a dominant-negative mutant for CaMKIV. Biswas et al. (1999) recently showed that elevated cytosolic calcium concentration observed after mitochondrial activity inhibition leads to increased transcription of the ryanodine receptor-1 Ca 2+ release channel and COX Vb genes. We also found an increase in the [Ca 2+ ] cyt in cells showing a mitochondrial activity impairment, and data obtained with mitochondrial aequorin overexpression suggest that the cytosolic increase induced by metabolic inhibitors is accompanied by a decrease in the mitochondrial calcium pool. Interestingly, hereditary defects in mitochondrial proteins such as pyruvate dehydrogenase (PDH) that decrease aerobic metabolism have been linked to reduced mitochondrial Ca 2+ uptake and sequestration (Padua et al., 1998) .
How do we explain the sustained CaMKIV activity observed in both mtDNA-depleted L929 cells and cells treated with metabolic inhibitors? The hypothesis of preexisting complexes containing active protein kinases and phosphatases suggests an attractive mechanism by which the appropriate phosphorylation state of the kinase is regulated. Phosphorylation of CaMKIV is required to generate autonomous activity, and PP2A is a constitutively active phosphatase that turns down the activity of CaMKIV (Westphal et al., 1998) . Immunoprecipitation of CaMKIV and analyses of the immune complexes by immunoblotting with an anti-PP2A antibody indicate that PP2A interaction with CaMKIV is very weak in both mtDNA-depleted L929 cells and cells treated with inhibitors. However, as the interaction can be inhibited by increasing the calcium concentration with ionomycin, it seems that the association is calcium dependent. Furthermore, KN-93 treatment that inhibits CaMKIV activity allows a stronger interaction in mtDNA-depleted cells. One can thus imagine that the physical interaction between PP2A and CaMKIV is modulated by calcium and the activity of CaMKIV.
CREB family members have been described as important transcription factors regulating cell proliferation and other nuclear responses (De Cesare et al., 1999) . Stimulation of the cAMP/PKA signal transduction pathway inhibits proliferation of some tumoral cell lines (Yokozaki et al., 1992) and inhibits proliferation of activated hepatic stellate cells (Houglum et al., 1997) . In culture, mtDNA-depleted cells or PDH-de®cient ®bro-blasts replicated far more slowly than normal cells (Buchet and Godinot, 1998; Padua et al., 1998) .
We ®rst examined the role of CREB on cell proliferation by treating cells with forskolin, which inhibits L929 cell proliferation by 40±50%. We then con®rmed that inhibition of mitochondrial respiratory function, induced by either oligomycin or mtDNA depletion, decreases cell [ 3 H]thymidine incorporation and thus inhibits cell progression to G 1 (Sweet and Singh, 1995) . Here, we found that cells transfected with dominant-negative mutants K-CREB or M1-CREB are almost insensitive to cell proliferation inhibition induced by oligomycin. Furthermore, these mutants suppress the cell proliferation defect observed in mtDNA-depleted L929 cells. These results suggest that phosphorylated CREB contributes to the control of cell cycle progression. CREB activation could thus explain why doubling time is higher for mtDNAdepleted L929 cells, an observation commonly reported for other mtDNA-depleted cell lines (Buchet and Godinot, 1998) .
Although little is known about the numerous mechanisms by which CREB affects the cell cycle, they could be mediated through molecular interactions between phosphorylated CREB and CBP, a key integrator of cellular functions (Kamei et al., 1996) , or transcription factors such as p53 tumor suppressor protein (Giebler et al., 2000) . Here, we demonstrate that, in mtDNA-depleted L929 cells, phosphorylated CREB physically interacts with p53 tumor suppressor protein and increases p53 transcriptional activity as assessed in a p53-dependent luciferase assay. p53 transcriptional activation in mtDNAdepleted cells can be suppressed by either M1-CREB or CaMKIV T200A overexpresssion. However, p53 protein expression is equal in both L929 and mtDNA-depleted cells. These results suggest that the increase of p53 transcriptional activity in mtDNA-depleted L929 cells is mediated through phosphorylated CREB, which recruits p53 protein and modi®es its transcriptional activity. Among p53-inducible genes, the p21 Waf1/cip1 gene encodes a protein that inhibits cyclin-dependent kinase activity and leads to G 1 growth arrest (el-Deiry et al., 1993) . Indeed, as evidence of p53 activation in mtDNA-depleted L929 cells, we found that p21 Waf1/Cip1 protein is more abundant in this cell line. The mechanism by which phosphorylated CREB triggers the transactivation of p53 in mtDNA-depleted cells, while p53 protein abundance is equal, is unknown. However, CBP acetylates not only histones but also transcription factors such as p53, c-Myb, E2-F and GATA-1 and increases their DNA sequence-speci®c binding capacity (Sano and Ishii, 2001 ).
In conclusion, the results show that CaMKIV may be involved in the calcium-dependent transcriptional regulation of genes in mitochondria-de®cient cells through phosphorylation of CREB. This transcription factor could mediate calcium-induced transcription of immediate-early genes or genes encoding mitochondrial proteins and containing CRE sequences (Soderling, 1999) . Indeed, CREB has been suspected to play a role in the regulation of the expression of several mitochondrial proteins such as respiratory chain subunits (Scacco et al., 2000) , cytochrome c (Gopalakrishnan and Scarpulla, 1994) , manganese superoxide dismutase (Kim et al., 1999) and carnitine palmitoyltransferase (Brady et al., 1992) . In this study, we demonstrated that phosphorylated CREB induced by a mitochondrial dysfunction is not only involved in transcriptional regulation of a target gene such as c-fos but can also be seen as a factor that causes a cell cycle defect in cells with impaired OXPHOS. CREB, a regulator of the cell cycle and cellular differentiation program, is thus a new factor involved in the`retrograde signaling' and molecular communication between functionally impaired mitochondria and the nucleus in mammalian cells.
Materials and methods

Cell cultures
The 143B, r0 143B, wild-type MERRF cybrids, mutated (A8344G) MERRF cybrids, L929 and mtDNA-depleted L929 cell lines have been described previously (King and Attardi, 1989; Schulze-Osthoff et al., 1993) . Human embryonic kidney 293 cells were from ATCC. The different cell lines were grown in high glucose (4.5 g/l) Dulbecco's modi®ed Eagle's medium (DHG) supplemented with 10% fetal bovine serum (FBS; Gibco-BRL) in a 5% CO 2 incubator. mtDNA-depleted L929 and r0 143B cells were grown in the presence of 400 ng/ml EtBr (Sigma), 50 mg/ml uridine and 1 mM pyruvate.
Immuno¯uorescence confocal laser scanner microscopy Cells were ®xed and permeabilized with methanol/acetone (20/80%), rinsed three times with phosphate-buffered saline (PBS) and unspeci®c sites were blocked with 1% bovine serum albumin (BSA) in PBS. For phospho-CREB, cells were immunostained overnight at 4°C with a primary rabbit polyclonal antibody against phosphorylated CREB on Ser133 (NEBL) at 1:1000, while for COX I detection, cells were incubated for 1 h with a monoclonal antibody against mouse COX I protein (Molecular Probes) at a 1:20 dilution, washed three times with PBS, incubated with (1:1000) anti-rabbit or anti-mouse Alexa antibodies (Molecular Probes) for 1 h at 37°C and processed for confocal microscopy (Leica). mtDNA analysis Subcellular fractionation to obtain nuclear-and mitochondria-enriched fractions was performed and genomic DNA or mtDNA was prepared as previously described (Wiesner et al., 1991) . A speci®c mitochondrial genome fragment of 823 bp was ampli®ed by PCR using forward (5¢-TTTGGGAACTACTAGAATTGATCA-3¢) and reverse (5¢-GCTGGT-ATTCTAATTAAACTACTT-3¢) primers speci®c for the mouse mitochondrial D-loop. PCR was performed using 10 ng of mtDNA or genomic DNA for 30 cycles at the hybridization temperature of 50°C.
Luciferase assay 293, 143B, r0 143B, wild-type MERRF cybrids, mutated (A8344G) MERRF cybrids, L929 and mtDNA-depleted L929 cells seeded in 12-well plates were transiently transfected by the calcium phosphate method or Superfect reagent (Qiagen) with a luciferase reporter construct (0.5 mg/well) and a b-galactosidase (0.25 mg/well) expression vector. In some experiments, cells were treated with 20 mM BAPTA-AM (Molecular Probes) for 6 h or co-transfected with 0.5 mg/well of an expression vector encoding K-CREB, M1-CREB, full-length CaMKIV or a dominant-negative form, CaMKIV T200A. For p53 activity, cells were transiently co-transfected with 0.5 mg/well of a p53-responsive (pG13-Luc) reporter with the b-galactosidase construct, together with 1 mg of an empty vector, or of a plasmid encoding M1-CREB, CaMKIV T200A or a p53 expression plasmid (pC53-SN3). In some experiments, cells were treated with 10 mM forskolin for 16 h in the presence or absence of 10 mM H-89. Cells were then harvested and luciferase activity was determined in cleared lysates using the commercial ReporterÔ assay system (Promega) and normalized for b-galactosidase activity. Inhibitors were added for 16 h.
Cell proliferation index L929 and mtDNA-depleted L929 cells were seeded in 12-well dishes at 50 000 cells/well. After a 24 h period of serum starvation, proliferation was triggered by the addition of fresh medium supplemented with 10% FBS, and the next day cells were incubated with 2 mCi of [ 3 H]thymidine for 4 h. Cells were harvested and [ 3 H]thymidine incorporation was determined as previously described (Buck et al., 1994) and expressed as c.p.m./mg of proteins. In some conditions, 24 h before the addition of 8 mM oligomycin for 6 h or 10 mM forskolin for 24 h, L929 and mtDNAdepleted L929 cells were transiently transfected using Superfect reagent with 0.5 mg/well of a control vector, with constructs encoding M1-CREB, K-CREB or CaMKIV T200A. KN-93 (50 mM) was added to empty vector-transfected L929 and mtDNA-depleted L929 cells for 24 h.
Western blotting analysis
Immunoblotting analyses were performed with 10 mg of protein of cleared lysates after separation on a 10 or 12% SDS±polyacrylamide gel. PVDF membranes were blocked overnight at 4°C in 5% non-fat dry milk or BSA-TBST. Primary antibodies were either anti-c-fos (Santa Cruz) at 1:1000, anti-CaMKIV or anti-CaMKII (Santa Cruz) at 1:100, anti-PP2A C subunit (Santa Cruz) at 1:1000, anti-phospho-CREB (Upstate Biotechnology), anti-CREB (NEBL) (1 mg/ml) or anti-p21 (Santa Cruz) at 1:2500, anti-histone-1 (Santa Cruz) at 1:1000 and anti-p53 (PharMingen) at 2 mg/ml. For loading controls, immunoblotting for a-tubulin or histone H1 was performed on the same membranes after stripping or not, followed by incubation with horseradish peroxidasecoupled secondary antibodies (Dako), and were detected by chemiluminescence (NEN).
Co-immunoprecipitation experiments
Endogenous CaMKII and IV were immunoprecipitated respectively with 10 mg of an anti-CaMKII or IV antibody (Santa Cruz) from clear lysates of mtDNA-depleted L929 cells or L929 cells treated or not for 6 h with 1 mM antimycin A, 8 mM oligomycin or 10 mM FCCP. Immune complexes were immobilized by adding 75 ml of a protein G + protein A±agarose mixture (Oncogene), washed three times and 40 ml of sample buffer was added. Western blot analyses for the PP2A C subunit in lysates, immunoprecipitated CaMKIV and co-immunoprecipitated PP2A C subunit were performed. p53 was immunoprecipitated from the lysates of L929 and mtDNA-depleted cells with 10 mg of an anti-p53 (Ab-1/ epitope amino acids 371±380) before p53 and CREB were analyzed by western blotting.
In vitro kinase assays CaMKII or IV activity was determined after immunoprecipitation by measuring its ability to phosphorylate a synthetic CREB phosphopeptide with the sequence KRREILSRRPS(p)YR (NEBL) according to the procedure described in the Supplementary data.
Statistical analysis
All experiments were performed at least twice and one set of representative results is shown. Results are expressed as means 6 SD. Statistical signi®cance was determined by Scheffe Â's contrasts after analysis of variance (ANOVA1).
Supplementary data
Supplementary data for this paper are available at The EMBO Journal Online.
